SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 0.25 |
| Enterprise Value ($M) | 3.79 |
| Book Value ($M) | -7.47 |
| Book Value / Share | -3.49 |
| Price / Book | -0.03 |
| NCAV ($M) | -10.81 |
| NCAV / Share | -5.05 |
| Price / NCAV | -0.02 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -0.47 |
| Return on Equity (ROE) | -1.34 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.24 |
| Current Ratio | 0.40 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 7.29 |
| Assets | 10.64 |
| Liabilities | 18.10 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 5.11 |
| Operating Income | -10.30 |
| Net Income | -14.32 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -2.60 |
| Cash from Investing | -0.02 |
| Cash from Financing | -7.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Iroquois Capital Management, LLC | 9.99 | 1,405.83 | |
| 13G/A | Ayrton Capital LLC | 6.20 | -2.27 | |
| 13G/A | Intracoastal Capital, Llc | 4.99 | 226.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,344,877 | 4,942,889 | 27.21 | |
| 14,485,133 | 49,418,524 | 29.31 | |
| 1,337,914 | 6,065,758 | 22.06 | |
| 2,112,447 | 7,696,722 | 27.45 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PRQR – ProQR Therapeutics N.V. | PRTG – Portage Biotech Inc. |
| PTIX – Protagenic Therapeutics, Inc. | PULM – Pulmatrix, Inc. |
| QLGN – Qualigen Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io